Is Lunai Bioworks Inc halal to invest in?

As of July 2026, Lunai Bioworks Inc LNAI is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Lunai Bioworks Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lunai Bioworks Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Lunai Bioworks Inc?

Muslim investors may consider investing in Lunai Bioworks Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Lunai Bioworks Inc classified as HALAL?

Musaffa determines the Shariah status of Lunai Bioworks Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Lunai Bioworks Inc updated?

The Shariah compliance status of Lunai Bioworks Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Lunai Bioworks Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Lunai Bioworks Inc?

You can check the latest Shariah compliance status of Lunai Bioworks Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

LNAI Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Lunai Bioworks Inc is classified as halal.

HALAL

Report Source: 2026 3rd Quarter Report

Lunai Bioworks Inc. Stock Analysis LNAI

United States Health Care Nano Cap Report: Q3, 2026

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. The company is headquartered in Los Angeles, California and currently employs 29 full-time employees. The company went IPO on 2014-11-18. The company is engaged in harnessing advanced computational biology and AI/machine learning to accelerate drug discovery, diagnostics and strengthen biosecurity capabilities. Its segments include RENB, BioSymetrics and RENC. The RENB segment is engaged in developing new immunotherapies to combat cancer. BioSymetrics is engaged in integrating multimodal data sources, including genomics, imaging, electronic health records, and other real-world evidence, to advance biomarker discovery, therapeutic development, and precision medicine. RENC is developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection. From high-resolution phenotyping to predictive disease modeling, the Company is pioneering a new era of precision diagnostics-where early detection, patient stratification, and therapeutic targeting converge into a single, adaptive platform.

Key Statistics of Lunai Bioworks Inc (LNAI)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.12$2.20

Today's Open

$2.17

Volume

12.15K

P/E Ratio (TTM)

52 Week Range

$1.21$28.00

Market Cap

12.42M

Avg. Volume

46.69K

Dividend Yield

Financial Metrics & Statements of Lunai Bioworks Inc (LNAI)

Super Investors Invested in Lunai Bioworks Inc (LNAI)

FAQ's for Lunai Bioworks Inc (LNAI)

As of July 2026, Lunai Bioworks Inc LNAI is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lunai Bioworks Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Lunai Bioworks Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Lunai Bioworks Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Lunai Bioworks Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Lunai Bioworks Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.